Trials / No Longer Available
No Longer AvailableNCT01523379
Efficacy of Parecoxib on Patients With CRPS
Efficiacy of the Selctive COX-2-inhibitor Parecoxibe on the Pathological Low Pressure Pain Threshold (PPT) of Patients With Complex Regional Pain Syndrome (CRPS)
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Ruhr University of Bochum · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The complex regional pain syndrom is a weighty disease that often results in a lifelong disability. Mostly this disease appears unilateral after comparatively mundane fractures or operations. In early stages CRPS shows inflammatory processes. These inflammatory components can be seen as edema and vasodilatation. These inflammatory processes lead us to the hypothesis that selective COX-2-inhibitors might help patients with CRPS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Parecoxib | 90mg Parecoxib i.v. two times a day, two days in a row |
| DRUG | Placebo | NaCl i.v. two times a day, two days in an row |
Timeline
- First posted
- 2012-02-01
- Last updated
- 2012-04-25
Source: ClinicalTrials.gov record NCT01523379. Inclusion in this directory is not an endorsement.